Women’s Health Market - Forecast(2024 - 2030)

Report Code: HCR 92870 Report Format: PDF + Excel

Women’s Health Market Overview

The Women’s Health Market size was estimated at $32.4 billion in 2020, projected to grow at a CAGR of 4.2% during the forecast period 2021-2026. Women's health is the field of medicine concerned with the prevention and diagnosis of diseases and disorders affecting a woman's physical and emotional well-being. Women's health encompasses a broad variety of specialties and focus areas, including Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, and Polycystic Ovary Syndrome among others. Additionally, Changes in eating patterns, stress, and alcohol intake are also important contributors to hormonal imbalance in women.

Women are likely to have fertility problems as a result of this. The most common causes of infertility are ovulation complications, endometriosis, and polycystic ovarian syndrome (PCOS). Moreover women's well-being is a priority for governments and private organizations all over the world. One of the main factors expected to drive the demand in developing countries is women's coverage plans. Various insurance schemes in the United States and Australia, for example, provide preventive care for women without charging a copayment. However, the high costs associated with clinical services and stringent regulations along with certain side-effects associate with the drugs is predicted to pose a threat to the market's growth during the forecast period 2021-2026.

Women’s Health Market

Women’s Health Market Report Coverage

The report: “Women’s Health Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Women’s Health Market.

By Application: Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome and Others.
By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies and Others..
By Geography: North America (U.S, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Others), Asia-Pacific (China, Japan India, South Korea, Australia and Others), South America(Brazil, Argentina and others) and Rest of the World (Middle East and Africa).

Key Takeaways

  • Geographically, The North America region held 40.7% of the total market share in 2020 owing to the rising adoption of the women’s health products and supportive government programs and policy’s.
  • increase in the population of women over 60, an increase in the adoption of unhealthy lifestyle habits, and the launch of novel medicines for women are the major driving force for Women’s Health Market during forecast period 2021-2026.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Women’s Health Market.


Women’s Health Market - By Geography, 2020.

Women’s Health Market
For More Details on This Report - Request for Sample

Women’s Health Market Segment Analysis- By Application

On the basis of application, the market is divided into Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, Polycystic Ovary Syndrome and Others applications. Contraceptives segment account for the highest market share in 2020 owing to the rising prevalence of unintended pregnancies, and large number of birth-control pill product launches by key players. For instance According to a study conducted by The Guttmacher Institute, there were approximately 121 million unwanted pregnancies between 2015 and 2019. Corresponding to a global average of 64 women per 1,000, aged 15 to 49.

However as a result of the high fertility-related conditions in developing countries, the hormonal infertility segment is expected to expand rapidly owing to which the segment is projected to grow at a faster CAGR of 5.8% during the forecast period 2021-2026. Hormonal imbalances, such as prolactin, estrogen, and thyroid imbalances, are becoming more common in women as a result of factors such as stress, fueling demand for medication to improve health.

Women’s Health Market Segment Analysis - By Distribution Channel

Based on Distribution Channel, the Women’s Health Market is segmented into Online Pharmacies, Hospital Pharmacies, Retail Pharmacies and other channels. The hospital pharmacy segment accounted for the majority of the market share. The segment's dominance can be explained by the fact that most prescriptions for different treatments can only be administered after rigorous evaluations by qualified medical professionals at these facilities. Furthermore, government policies aimed at enhancing healthcare services and infrastructure have helped hospital pharmacies gain popularity among the general public thereby contributing to growth of the segment.

Online Pharmacies segment account for the highest market share in 2020 and is projected to grow at a CAGR of 5.9% during the forecast period 2021-2026. The dominance is due to evolving consumers and increasing demand from tier I and II cities where ecommerce penetration is increasing rapidly. Moreover, along with multiple options the customers can compare for the best price & features, from the comfort of their home or as per an individual’s preference which is further poised to increase the online Pharmacies segment.

Women’s Health Market Segment Analysis - By Geography

Based on geography, North America dominated the Women’s Health Market with a region share of 40.7% in 2020 followed by Europe and APAC. Rising adoption of the women’s health products and supportive government programs and policies are the major factors propelling the growth in this region. Furthermore, the presence of a large number of pharmaceutical companies that invest heavily in research, as well as easy access to technologically advanced instruments, is expected to propel market growth in this area.

However, Asia Pacific region is predicted to see the demand maturing in Women’s Health Market owing to the rising spending in emerging economies such as China and India, as well as increased concern about women's health. Furthermore, policymakers in developing countries are taking steps to raise awareness about Postmenopausal Osteoporosis, Infertility, Endometriosis diseases along with their diagnosis and treatment options which is further predicted to drive the market during the forecast period 2021-2026.

Women’s Health Market Drivers

Increasing incidence of Chronic Disease

Frequent outbreaks of diseases, such as anemia, osteoporosis, breast cancer, and menopause, have sparked a surge in demand for products to treat these illnesses affecting women. Growing public understanding of these diseases, their adverse consequences, and potential early detection and treatment approaches to avoid future outbreaks are expected to drive global market development. Furthermore, the easy availability of several medicines to treat hormonal imbalances along with the increasing investments by key market player and government organizations around the world, is set to propel the market forward during the forecast period 2021-2026.

Women’s Health Market Challenge

High Cost of the Product

Despite the increased diseases and supportive government programs and policy’s, some factors are preventing product acceptance. The high costs associated with clinical services along with certain side-effects associate with the drugs is currently limiting the adoption of the products. Moreover the rising stringency in the government regulation also poses a major threat thereby, acting as major impediment for market's growth.

Women’s Health Market Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Women’s Health Market. Key companies of this market are Allergan, Bayer AG, Merck & Co., Inc., Pfizer, Teva Pharmaceuticals, Agile Therapeutics, Amgen, Inc., AstraZeneca, Bristol-Myers Squibb and Ferring B.V.

Developments:

  • In June 2019, AbbVie Inc. announced that it had reached an agreement with ALLERGAN to purchase the assets available with ALLERGAN for approximately USD 63 billion. This acquisition is a strategic move for the companies because their combined expertise would open up a wide range of applications thereby driving innovation in the Women’s Health Market.
  • In May 2019, Agile Therapeutics resubmitted its Twirla new drug application in response to a Complete Response Letter from the FDA in December 2017, which found flaws in the product's manufacturing process quality control.

Relevant reports

Report Code: HCR 0222

Report Code: HCR 0269

For more Lifesciences and Healthcare Market reports - Please click here

1. Women’s Health Market Overview
    1.1 Definitions and Scope
2. Women’s Health Market Executive Summary
    2.1 Market Revenue, Market Size and Key Trends
    2.2 Key trends By Application
    2.3 Key trends By Distribution Channel
    2.4 Key trends By Geography
3. Women’s Health Market Landscape
    3.1 Product Benchmarking- Key Companies
    3.2 Financial Analysis- Key Companies
    3.3 Patent Analysis
    3.4 Pricing Analysis–Average Pricing
4. Women’s Health Market- Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Women’s Health Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Women’s Health Market Forces
    6.1 Market Drivers
    6.2 Market Constraints and Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Women’s Health Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Women’s Health Market– By Application
    8.1 Osteoporosis
    8.2 Hormonal Infertility
    8.3 Endometriosis
    8.4 Contraceptives
    8.5 Menopause
    8.6 Polycystic Ovary Syndrome (PCOS)
    8.7 Others
9. Women’s Health Market– By Distribution Channel
    9.1 Online Pharmacies
    9.2 Hospitals Pharmacies
    9.3 Retail Pharmacies
    9.4 Others
10. Women’s Health Market- By Geography
    10.1 North America
        10.1.1 U.S
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 U.K
        10.2.2 Germany
        10.2.3 France
        10.2.4 Spain
        10.2.5 Italy
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia Pacific
        10.3.1 India
        10.3.2 China
        10.3.3 Japan
        10.3.4 Australia
        10.3.5 South Korea
        10.3.6 Rest of Asia pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Rest of South America
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Women’s Health Market Entropy
12. Women’s Health Market- Industry / Segment Competition landscape Premium Premium
    12.1 Market Share Analysis
        12.1.1 Market Share by Country- Key companies
        12.1.2 Market Share by Region- Key companies
        12.1.3 Market Share at Global Level- Key companies
        12.1.4 Best Practices for Companies
13. Women’s Health Market- Key Company List by Country Premium Premium
14. Women’s Health Market Company Analysis (Company Revenue, Products, M&A, Developments)
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Competitive Landscape Market 2023-2030 ($M)
2.Global Competitive Landscape Market 2023-2030 (Volume/Units)
3.North America Competitive Landscape Market 2023-2030 ($M)
4.South America Competitive Landscape Market 2023-2030 ($M)
5.Europe Competitive Landscape Market 2023-2030 ($M)
6.APAC Competitive Landscape Market 2023-2030 ($M)
7.MENA Competitive Landscape Market 2023-2030 ($M)

LIST OF FIGURES

1.US Womens Health Market Revenue, 2023-2030 ($M)
2.Canada Womens Health Market Revenue, 2023-2030 ($M)
3.Mexico Womens Health Market Revenue, 2023-2030 ($M)
4.Brazil Womens Health Market Revenue, 2023-2030 ($M)
5.Argentina Womens Health Market Revenue, 2023-2030 ($M)
6.Peru Womens Health Market Revenue, 2023-2030 ($M)
7.Colombia Womens Health Market Revenue, 2023-2030 ($M)
8.Chile Womens Health Market Revenue, 2023-2030 ($M)
9.Rest of South America Womens Health Market Revenue, 2023-2030 ($M)
10.UK Womens Health Market Revenue, 2023-2030 ($M)
11.Germany Womens Health Market Revenue, 2023-2030 ($M)
12.France Womens Health Market Revenue, 2023-2030 ($M)
13.Italy Womens Health Market Revenue, 2023-2030 ($M)
14.Spain Womens Health Market Revenue, 2023-2030 ($M)
15.Rest of Europe Womens Health Market Revenue, 2023-2030 ($M)
16.China Womens Health Market Revenue, 2023-2030 ($M)
17.India Womens Health Market Revenue, 2023-2030 ($M)
18.Japan Womens Health Market Revenue, 2023-2030 ($M)
19.South Korea Womens Health Market Revenue, 2023-2030 ($M)
20.South Africa Womens Health Market Revenue, 2023-2030 ($M)
21.North America Womens Health By Application
22.South America Womens Health By Application
23.Europe Womens Health By Application
24.APAC Womens Health By Application
25.MENA Womens Health By Application